The Study
Copeptin as a dual biomarker in type 2 diabetes: association with glycemic control and diabetic kidney disease
This study found that people with worse diabetes and kidney problems tend to have higher levels of a substance called copeptin. But it didn't watch them over time, so we don't know if high copeptin causes the problems or if the problems cause high copeptin — it's just a snapshot.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
This study looked at a protein called copeptin in the blood of people with type 2 diabetes to see if it could show how well their blood sugar is controlled and if their kidneys are getting damaged.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 544 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this means a simple blood test for copeptin might help doctors spot people at high risk for worsening diabetes or kidney damage before other signs appear.
- 2Copeptin levels were much higher in people with HbA1c over 7% (bad control) and in those with kidney disease.
- 3A level above 3452 pg/mL predicted bad control with 90% accuracy; above 370 pg/mL predicted kidney damage with 95% accuracy.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
BMC Endocrine Disorders
Year
2026
Authors
N. K. Rakha, Ahmed Fayed, Shady A. Ramiz, E. Elsayed, Sameh A Al-Dawy, Fadia Moris Bolis, Ahmed Fathy, Sameh Abouzeid, Rasha Ahmed Darwish, Mohammed Gomaa, H. Elsheimy
Related Content
Claims (6)
People with persistently high levels of copeptin in their blood have a higher likelihood of developing type 2 diabetes compared to those with lower levels.
Adults with type 2 diabetes have higher levels of copeptin in their blood than healthy adults, and those with worse blood sugar control or kidney disease have even higher levels. Copeptin levels strongly correlate with blood sugar, kidney function markers, and kidney filtration rate.
In adults with type 2 diabetes, a blood copeptin level above 3452 pg/mL indicates poor blood sugar control (HbA1c >7%), and a level above 370 pg/mL indicates diabetic kidney disease, based on measured sensitivity and specificity values.
In adults with type 2 diabetes, higher levels of copeptin in the blood are consistently linked to higher levels of HbA1c, which reflects worse long-term blood glucose control.
Adults with type 2 diabetes and high blood sugar (HbA1c >7%) have higher levels of copeptin in their blood than those with better-controlled blood sugar (HbA1c ≤7%).
In adults with type 2 diabetes, higher levels of copeptin in the blood are consistently linked to lower kidney filtration capacity as measured by eGFR.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.